<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For most of the 20th century, subclassification of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) was based on the resemblance of blasts to <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>This approach was standardized by the French-American-British (FAB) group </plain></SENT>
<SENT sid="2" pm="."><plain>Because of limited clinical relevance, clinicians resorted to other patient characteristics to determine treatment and predict outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A different approach based on the relationship of a case to <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) has been proposed </plain></SENT>
<SENT sid="4" pm="."><plain>The new World Health Organization (WHO) subclassification of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> includes elements of this new proposal but retains as a major category the historical subclassification </plain></SENT>
<SENT sid="5" pm="."><plain>The WHO group has also proposed modifications of the FAB subclassification of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> proposals have generated discussion of diagnostic criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and a philosophical discussion of whether <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> should still be considered a syndrome, or rather a specific set of diseases characterized by genetic instability and poor outcome </plain></SENT>
</text></document>